18th Annual · January 2020 · In person
2020
- 27 faculty
- 32 recordings
- 22 slide decks
Symposium
Application of NIA-AA Research Framework
Saturday, January 18, 2020 · 8:15 am - 5:25 pm
- 7:15 am - 8:15Check-in and Continental Breakfast
- 8:00 - 8:15The ATN Framework: Background and Importance
8:15 - 11:25
Session 1
Application of NIA-AA Research Framework in the Real World
Chair: Reisa Sperling, MDHarvard Medical School
- 8:15 - 8:50Keynote NIA-AA Framework for Alzheimer’s Disease Research: Implications for Mild Cognitive Impairment
- 8:50 - 9:10The ATN Framework: Prediction of Progression from MCI to AD Dementia
- 9:10 - 9:30The ATN Framework: Prediction of Progression from Normal Cognition to MCI
- 9:30 - 9:50The ATN Framework: The Importance of Lifestyle Factors in Predicting Progression
- 9:50 - 10:10The ATN Framework: The Good, the Bad, and the Ugly
- 10:10 - 10:35BREAK
- 10:35 - 10:55Application of the ATN Framework in African Americans and Caucasians
- 10:55 - 11:25
11:25am - 2:30 pm
Session 2
Application of Technology for Early Diagnosis and Assessment of MCI
Chair: Demetrius Maraganore, MD, FAANUniversity of Florida
- 11:25 - 11:30Technology for Early Diagnosis and Assessment of MCI: Background, Importance and Trends
- 11:30 - 12:05Keynote Assessment of the Aging Brain Using Computing Technology
- 12:05 - 1:00LUNCH
- 1:00 - 1:20Biomedical Informatics and eHealth Core (BMI-EH), 1FLORIDA ADRC
- 1:20 - 1:40A Novel Method for Assessing and Training Everyday Functional Skills
- 1:40 - 2:00The Brain Health Registry: Use of Web-based Technology for Detecting and Monitoring Changes in Cognition and Alzheimer’s Disease Risk
- 2:00 - 2:30
2:30 - 5:25
Session 3
Synucleinopathies and MCI- Biology, Diagnosis, Progression and Treatment
Chair: James Galvin, MD, MPHUniversity of Miami Miller School of Medicine
- 2:30 - 2:35Synucleinopathies and MCI: Background
- 2:35 - 3:10Keynote The Role of Alpha-synuclein Aggregates in the Pathogenesis of Lewy Body and Parkinson’s Disease
- 3:10 - 3:35BREAK
- 3:35 - 3:55Screening and Clinical Diagnosis of Lewy Body Disease
- 3:55 - 4:15
- 4:15 - 4:35Treating Dementia with Lewy Bodies: Beyond Medications
- 4:35 - 4:55The Unraveling Story of Tyrosine Kinase Inhibition in Parkinson's Disease and Dementia with Lewy Bodies
- 4:55 - 5:25
- 5:25 - 5:35Conclusions
- 5:35 - 7:30Networking Reception
Workshop
MCI and Dementia: From Epidemiology to Pathology
Sunday, January 19, 2020 · 8:30 am - 1:00 pm
- 7:30 am - 8:30Continental Breakfast and Check-in
8:30 - 8:40
Chair: Zoe Arvanitakis, MD, MSRush University
- 8:30 - 8:40MCI and Dementia: Reviewing the Spectrum from Epidemiology to Pathology
- 8:40 - 9:15Keynote The NIA-AA Research Framework: Implications for Clinical Care, Epidemiological and Genetic Studies
- 9:15 - 9:40Risk Factors and Progression Rates of MCI
- 9:40 - 10:05Cognitive Predictors of Disease Progression in Normal and At-risk States
- 10:05 - 10:30BREAK
- 10:30 - 10:55
- 10:55 - 11:20Paradoxical Aging in Alzheimer’s Disease: A Clinicopathologic Perspective
- 11:20 - 11:45TDP43 Pathology - Effect of Demographic Factors
- 11:45 - 12:15 pm
- 12:15 - 12:30 pmConclusions
- 12:30 - 1:00LUNCH
Public Forum
Mild Cognitive Impairment: How We Detect It, What Causes it, How We Can Prevent It
Sunday, January 19, 2020 · 1:30 pm - 5:30 pm
- 1:00 - 1:30pmCheck-in and Refreshments
1:30 - 5:00
Chair: Sudha Seshadri, MDGlenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases
- 1:30 - 1:40Mild Cognitive Impairment: Background and Importance
- 1:40 - 2:15Keynote How Your Lifestyle Can Protect Your Brain
- 2:15 - 2:40
- 2:40 - 3:05Web-based Technology to Screen and Monitor Cognitive Health
- 3:05 - 3:30Everything You Wanted to Know About LBD but Were Afraid to Ask
- 3:30 - 3:55BREAK
- 3:55 - 4:20
- 4:20 - 4:45Memory Compensation Training and Computerized Cognitive Training in MCI
- 4:45 - 5:15Panel Discussion and Q&A
- 5:15 - 5:30Conclusions
Programs, recordings and slides as published at the time. Slides and recordings appear only where speakers chose to share them. Affiliations are as of 2020.